Also known as

HN · Mitochondrial-derived peptide humanin · MDP

Overview

Humanin is a mitochondrial-derived peptide studied for cytoprotection, metabolic stress resilience, and longevity models. Research explores anti-apoptotic and insulin-sensitivity–adjacent endpoints.

It belongs to the MDP class alongside MOTS-c for nuclear-mitochondrial signaling work. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Cytoprotection and anti-apoptotic endpoints

• • Metabolic stress and insulin-sensitivity markers where studied

• • Neuro and cardiac cytoprotection readouts in literature

• • Longevity-model biomarkers for MDP research

• • Comparative mitochondrial-peptide pharmacology with MOTS-c

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 12: Early mitochondrial and energy-metabolism readouts; compound accumulating in model systems.

• • Week 3–4: Clearer redox, endurance, or cellular-energy markers in short preclinical windows.

• • Month 2–3: More pronounced metabolic and cytoprotection endpoints in extended designs.

• • Month 3–6: Sustained mitochondrial and aging-adjacent observations where studied longer.

Footer RUO

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.